These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9589425)
1. Why don't we have an HIV/AIDS vaccine? When will we have one? Miramontes HM J Assoc Nurses AIDS Care; 1998; 9(3):95-7. PubMed ID: 9589425 [No Abstract] [Full Text] [Related]
2. Why we don't have an HIV vaccine, and how we can develop one. Harris JE Health Aff (Millwood); 2009; 28(6):1642-54. PubMed ID: 19887405 [TBL] [Abstract][Full Text] [Related]
3. HIV vaccine development for the world: an idea whose time has come? Berkley S AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S191-6. PubMed ID: 9814943 [No Abstract] [Full Text] [Related]
4. Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. Long EF; Brandeau ML; Owens DK Vaccine; 2009 Aug; 27(39):5402-10. PubMed ID: 19591796 [TBL] [Abstract][Full Text] [Related]
5. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives. Hecht R; Suraratdecha C PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657 [TBL] [Abstract][Full Text] [Related]
6. Inventions innovate thyself. To accelerate the discovery of an affordable AIDS vaccine and other crucial health resources, experts say they will need to invent new ways to use intellectual property. Cohen P IAVI Rep; 2005; 9(5):14-6. PubMed ID: 16541502 [No Abstract] [Full Text] [Related]
7. The private demand for an AIDS vaccine in Thailand. Suraratdecha C; Ainsworth M; Tangcharoensathien V; Whittington D Health Policy; 2005 Mar; 71(3):271-87. PubMed ID: 15694496 [TBL] [Abstract][Full Text] [Related]
8. Future directions in HIV vaccine development. Koff WC; Glass MJ AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1313-5. PubMed ID: 1466948 [No Abstract] [Full Text] [Related]
9. No vaccine for 10 years. AIDS Patient Care STDS; 1999 Jun; 13(6):377. PubMed ID: 10842867 [No Abstract] [Full Text] [Related]
10. What if we had an AIDS vaccine? Lancet; 2000 Jul; 356(9224):85. PubMed ID: 10963237 [No Abstract] [Full Text] [Related]
11. Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative. Tucker TJ; Mazithulela G BMJ; 2004 Aug; 329(7463):454-6. PubMed ID: 15321907 [TBL] [Abstract][Full Text] [Related]
12. One step forward, two steps back--will there ever be an AIDS vaccine? Steinbrook R N Engl J Med; 2007 Dec; 357(26):2653-5. PubMed ID: 18160684 [No Abstract] [Full Text] [Related]
13. Aches and pains. Learning lessons from the influenza vaccine shortage. Fink S IAVI Rep; 2004 Dec-2005 Mar; 9(1):10-1. PubMed ID: 16110570 [No Abstract] [Full Text] [Related]
14. Funding support lacking in search for HIV vaccine. AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091 [TBL] [Abstract][Full Text] [Related]
16. The potential global market size and public health value of an HIV-1 vaccine in a complex global market. Marzetta CA; Lee SS; Wrobel SJ; Singh KJ; Russell N; Esparza J Vaccine; 2010 Jul; 28(30):4786-97. PubMed ID: 20471439 [TBL] [Abstract][Full Text] [Related]
17. NIAID funds center for HIV/AIDS vaccine immunology. AIDS Policy Law; 2005 Jul; 20(14):2. PubMed ID: 16108120 [No Abstract] [Full Text] [Related]
18. Market incentives, human lives, and AIDS vaccines. Craddock S Soc Sci Med; 2007 Mar; 64(5):1042-56. PubMed ID: 17113203 [TBL] [Abstract][Full Text] [Related]